Cisplatin: all 1,649 studies that test it
Page 11 of 17. Open to participants first (223), then studies with results posted, then the rest; newest registration first within each.
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent OsteosarcomaCompletedNCT01650090Phase 2
- A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With CisplatinTerminatedNCT01641575Phase 1
- Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachCompletedNCT01640782Phase 3
- Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT01633645Phase 2
- Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer PatientsCompletedNCT01611727Phase 2
- Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus CancerTerminatedNCT01608464Phase 2
- A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesSuspendedNCT01604863Phase 1
- GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest ChinaCompletedNCT01596868Phase 2
- Concurrent Chemoradiotherapy for Cervical Cancer in Elderly WomenStatus unknownNCT01594099Phase 2
- Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma CervixStatus unknownNCT01593306Phase 3
- Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)CompletedNCT01579929Phase 1
- Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain MetastasesCompletedNCT01578668Phase 2
- Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)TerminatedNCT01573338Phase 1/2
- A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural MesotheliomaStatus unknownNCT01569919Phase 2
- Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung CancerTerminatedNCT01565772Phase 1
- Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLCCompletedNCT01562210Phase 1
- Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical CancerStatus unknownNCT01561586Phase 3
- Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical CarcinomaCompletedNCT01554410Phase 1
- Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal CarcinomaCompletedNCT01528618Phase 3
- A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric CancerCompletedNCT01517009Phase 2
- Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid TumorsTerminatedNCT01496534Phase 1
- Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT01491139Phase 1
- Pemetrexed and Cisplatin in Advanced Urothelial CarcinomaCompletedNCT01490437Phase 2
- A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland TumorsCompletedNCT01488838Phase 2
- Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical CancerCompletedNCT01485731Phase 1
- Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerCompletedNCT01471470Phase 2
- Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck CancerCompletedNCT01467115Phase 2
- Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial CancerStatus unknownNCT01461759Phase 2
- Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial CancerStatus unknownNCT01461746Phase 2
- Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced CancerCompletedNCT01460537Phase 1
- Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNCT01445405Phase 1
- A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and CisplatinStatus unknownNCT01444547Phase 2
- Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric CancerCompletedNCT01444521Phase 2
- Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell TumorsStatus unknownNCT01424839Phase 4
- Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01424709Phase 2
- Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01417390Phase 2
- XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric CancerStatus unknownNCT01412294Phase 2
- Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT01411098Phase 1
- IPI Biochemotherapy for Chemonaive Patients With Metastatic MelanomaTerminatedNCT01409174Phase 1
- MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung CancerStatus unknownNCT01405586Phase 3
- Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase ExpressionStatus unknownNCT01401192Phase 2
- Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic CancerCompletedNCT01396681Phase 2
- Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic CancerCompletedNCT01396668Phase 2
- Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck CancerCompletedNCT01384799Phase 1
- Cisplatin and Pemetrexed With Radiation Followed by LobectomyTerminatedNCT01373463Phase 1
- Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck CancerStatus unknownNCT01372111Phase 2
- Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)CompletedNCT01368848Phase 2
- EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01360827Phase 1
- Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionCompletedNCT01360086Phase 2
- Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung CancerTerminatedNCT01356368Phase 2
- Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung CancerSuspendedNCT01356303Phase 2
- Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell LymphomaCompletedNCT01345357Phase 1
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsCompletedNCT01336842Phase 1
- Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or AscitesCompletedNCT01327235Phase 2
- Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)CompletedNCT01326559Phase 2
- PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)CompletedNCT01320254Phase 2
- Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal CancerStatus unknownNCT01312311Phase 2
- Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
- A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive CancerCompletedNCT01304784Phase 1
- A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid TumorsCompletedNCT01301716Phase 1
- A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyCompletedNCT01297998Phase 1
- Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical CancerStatus unknownNCT01295502Phase 1
- Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)CompletedNCT01287624Phase 3
- Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract CancerCompletedNCT01284413Phase 1/2
- Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric CancerCompletedNCT01283204Phase 2
- Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCCTerminatedNCT01283178Phase 1
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT01281852Phase 1
- Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
- Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and NeckCompletedNCT01275183Early Phase 1
- A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric CancerCompletedNCT01269255Phase 1
- Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung CancerCompletedNCT01266512Phase 2
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of ResponseTerminatedNCT01258634Phase 1
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer PatientsCompletedNCT01258192Phase 2
- Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01245959Phase 3
- ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract CancerCompletedNCT01242605Phase 1
- ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal JunctionCompletedNCT01234324Phase 2
- Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical CancerCompletedNCT01230996Phase 1/2
- Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of EsophagusCompletedNCT01225523Phase 1
- Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderStatus unknownNCT01222676Phase 2
- Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By SurgeryActive, not recruitingNCT01220583Phase 2
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNCT01192165Phase 1
- The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal CarcinomaCompletedNCT01187238Phase 2
- Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATECompletedNCT01187212Phase 2
- A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01171781Phase 2
- Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid TumorsCompletedNCT01165385Phase 1
- Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerWithdrawnNCT01160731Phase 1
- Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical CancerStatus unknownNCT01158248Phase 2
- Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT01154920Phase 2
- Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic CancerCompletedNCT01150630Phase 2
- Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast CancerCompletedNCT01143974Phase 4
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian CancerWithdrawnNCT01138137Phase 1
- Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT01134861Phase 3
- A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsStatus unknownNCT01131429Phase 2
- Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT01125020Not applicable
- Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).CompletedNCT01116219Phase 2
- Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung MetastasesCompletedNCT01114958Phase 1
- Trial Of Cisplatin And KML-001 in Platinum Responsive MalignanciesTerminatedNCT01110226Phase 1
- AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWithdrawnNCT01105390Phase 2
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerCompletedNCT01104259Phase 1